Alzamend Neuro, Inc.

ALZN·NasdaqCM·Healthcare
Compare
1.5300+0.0700 (+4.79%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.4600
Open1.5350
Day range1.48011.6197
52-week range0.84002.6100
Off day high−5.54%
Off 52-week high−41.38%
Volume72.07K
Avg. volume (3M)81.23K
Market cap7.38M
EPS (TTM)-2.30
Forward P/E-1.76
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.43
Shares outstanding4.83M
Short interest0.73% of float
Earnings dateJul 28, 2025 (est.)
Analyst target26.0000
Profit margin0.00%

Against its peers

Compare in full ›
ALZN NRSN ADXN NEUP SILO ALEC
Market cap 7.38M 2.69M 5.33M 16.13M 2.93M 254.58M
P/E (TTM) — — — — — —
Forward P/E -1.8 -0.3 -60.9 -1.2 -1.9 -3.1
Price/book 1.3 -1.5 1.4 0.7 0.3 -25.6
Dividend yield — — — — — —
1-year change −42.75% −93.90% −65.26% −32.05% −82.01% +75.38%
Today +4.79% +9.23% +1.27% −0.33% +3.91% +11.22%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ALZN news ›

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance